OLMA vs. ACLX

In the year-to-date period, OLMA achieves a -19.21% return, which is significantly higher than ACLX's -23.35% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Olema Pharmaceuticals, Inc. (OLMA) and Arcellx Inc (ACLX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current OLMA Sharpe Ratio is -0.66, which is lower than the ACLX Sharpe Ratio of 0.20. The chart below compares the historical Sharpe Ratios of OLMA and ACLX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither OLMA nor ACLX has paid dividends to shareholders.

The maximum OLMA drawdown since its inception was -96.26%, which is greater than ACLX's maximum drawdown of -62.33%. Use the drawdown chart below to compare losses from any high point for OLMA and ACLX. For additional features, visit the drawdowns tool.

Olema Pharmaceuticals, Inc. (OLMA) has a higher volatility of 24.39% compared to Arcellx Inc (ACLX) at 22.83%. This indicates that OLMA's price experiences larger fluctuations and is considered to be riskier than ACLX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Olema Pharmaceuticals, Inc. and Arcellx Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.